<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

SpyGlass Pharma Randomizes First Patients in Phase 3 Trials of BIM-IOL System for Glaucoma

Default sub title

minute read

by Eyewire | January 21, 2026
placeholder

Topics: Press Coverage